Digital Music News on MSN1h
Warner Music Reports Q4 2024 Revenue Slip As Paid Streaming Concerns Persist — U.S. Recorded Revenue Falls 15% YoY
Warner Music Group has acknowledged encountering “some pressure” during the final three months of 2024, when its U.S.
Neurocrine Biosciences targets $2.5B-$2.6B INGREZZA sales for 2025 amid expanded sales force
Q4 2024 Management View CEO Kyle Gano highlighted Neurocrine's transformation into a fully integrated biopharmaceutical company. He emphasized the strong performance of INGREZZA, which is poised for ...